Literature DB >> 20103278

Managing fibrinolysis without aprotinin.

L Henry Edmunds1.   

Abstract

Cardiopulmonary bypass increases perioperative bleeding and produces a consumptive coagulopathy, which is defined as the simultaneous production of thrombin and fibrinolysis. Thrombin formation and fibrinolysis primarily occur in the surgical wound and peak at the time heparin is reversed by protamine. Neither aprotinin nor lysine analogs successfully control bleeding in many complex procedures, reoperations, aortic resections, or in implantations of mechanical circulatory devices. This analysis reviews the mechanisms involved and current treatment protocols, with the conclusion that changes in treatment protocols rather than use of a specific anti-fibrinolytic drug may provide better control of bleeding in these patients. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103278     DOI: 10.1016/j.athoracsur.2009.10.043

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Early postoperative outcomes and blood product utilization in adult cardiac surgery: the post-aprotinin era.

Authors:  Stacia M DeSantis; J Matthew Toole; John M Kratz; Walter E Uber; Margaret J Wheat; Martha R Stroud; John S Ikonomidis; Francis G Spinale
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

Review 2.  Fibrinolysis and the control of blood coagulation.

Authors:  John C Chapin; Katherine A Hajjar
Journal:  Blood Rev       Date:  2014-09-16       Impact factor: 8.250

3.  Continuous localized monitoring of plasmin activity identifies differential and regional effects of the serine protease inhibitor aprotinin: relevance to antifibrinolytic therapy.

Authors:  Daryl L Reust; Jennifer A Dixon; Richard A McKinney; Risha K Patel; William T Rivers; Rupak Mukherjee; Robert E Stroud; Karen Madden; Kevin Groves; Milind Rajopadhye; Scott T Reeves; James H Abernathy; Francis G Spinale
Journal:  J Cardiovasc Pharmacol       Date:  2011-04       Impact factor: 3.105

4.  Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.

Authors:  Daryl L Reust; Scott T Reeves; James H Abernathy; Jennifer A Dixon; William F Gaillard; Rupak Mukherjee; Christine N Koval; Robert E Stroud; Francis G Spinale
Journal:  Ann Thorac Surg       Date:  2010-05       Impact factor: 4.330

5.  The hemostatic disturbance in patients with acute aortic dissection: A prospective observational study.

Authors:  Xinliang Guan; Jiachen Li; Ming Gong; Feng Lan; Hongjia Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 6.  Bleeding related to disturbed fibrinolysis.

Authors:  Krasimir Kolev; Colin Longstaff
Journal:  Br J Haematol       Date:  2016-08-01       Impact factor: 6.998

7.  Intraoperative collection of autologous platelet-rich plasma from the cardiopulmonary bypass circuit upon initiation of extracorporeal circulation.

Authors:  Takeshi Honda; Yuji Kanaoka; Hiroshi Furukawa; Taishi Tamura; Noriaki Kuwada; Takahiko Yamasawa; Yoshiko Watanabe; Yasuhiro Yunoki; Atsushi Tabuchi; Kazuo Tanemoto
Journal:  J Cardiothorac Surg       Date:  2021-02-05       Impact factor: 1.637

8.  PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass.

Authors:  Agnese Ozolina; Eva Strike; Inta Jaunalksne; Angelika Krumina; Lars J Bjertnaes; Indulis Vanags
Journal:  BMC Anesthesiol       Date:  2012-10-30       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.